SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Atom Investors LP

Atom Investors LP reduced its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 65.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 34,775 shares of the exchange traded fund’s stock after selling 65,681 shares during the quarter. Atom Investors LP’s holdings in SPDR S&P Biotech ETF were worth $3,436,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in XBI. Point72 Hong Kong Ltd acquired a new position in SPDR S&P Biotech ETF during the third quarter worth approximately $296,000. FSA Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $74,000. Edgestream Partners L.P. increased its holdings in shares of SPDR S&P Biotech ETF by 30.8% during the 3rd quarter. Edgestream Partners L.P. now owns 13,171 shares of the exchange traded fund’s stock worth $1,301,000 after buying an additional 3,103 shares during the last quarter. Verition Fund Management LLC raised its position in shares of SPDR S&P Biotech ETF by 18.2% in the 3rd quarter. Verition Fund Management LLC now owns 98,292 shares of the exchange traded fund’s stock worth $9,711,000 after buying an additional 15,116 shares during the period. Finally, Captrust Financial Advisors boosted its holdings in SPDR S&P Biotech ETF by 135.5% in the third quarter. Captrust Financial Advisors now owns 18,252 shares of the exchange traded fund’s stock valued at $1,803,000 after acquiring an additional 10,501 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 0.4 %

XBI stock opened at $99.62 on Monday. The company has a market cap of $7.59 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a 50-day moving average price of $98.22 and a two-hundred day moving average price of $96.61. SPDR S&P Biotech ETF has a 12-month low of $74.20 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.